An in vitro investigation of genotoxic effects of dexketoprofen trometamol on healthy human lymphocytes

References

• Albertini, R.J., et al., 2000. IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. Mutation Research, 463 (2), 111–172.
   PubMed Web of Science ®Google Scholar
• Aykaç, E., 2010. Spinal Anestezi Altındaki Elektif Sezaryen Olgularında İv Deksketoprofen Trometamolün Postoperatif Analjezik Etkinliğinin Lornoksikam Ve Plasebo İle Karşılattırılması. Kırıkkale Üniversitesi Tıp Fakültesi Uzmanlık Tezi, Kırıkkale
   Google Scholar
• Aykaç, E., et al., 2012. Sezaryen İle Doğum Sonrası Ağrıda Deksketoprofen Trometamolün Analjezik Etkisinin Lornoksikam Ve Plasebo İle Karşılaştırılması. Journal of Anesthesia, 20 (2), 80–85.
   Google Scholar
• Barbanoj, M.J., Antonijoan, R.M., and Gich, I., 2001. Clinical pharmacokinetics of dexketoprofen. Clinical Pharmacokinetics, 40 (4), 245–262.
   PubMed Web of Science ®Google Scholar
• Botting, R., and Ayoub, S.S., 2005. COX-3 and the mechanism of action of paracetamol/acetaminophen. Prostaglandins, Leukotrienes, and Essential Fatty Acids , 72 (2), 85–87.
   PubMed Web of Science ®Google Scholar
• Dannhardt, G., and Kiefer, W., 2001. Cyclooxygenase inhibitors – current status and future prospects. European Journal of Medicinal Chemistry, 36 (2), 109–126.
   PubMed Web of Science ®Google Scholar
• Dannhardt, G., and Laufer, S., 2000. Structural approaches to explain the selectivity of COX-2 inhibitors: is there a common pharmacophore? Current Medicinal Chemistry, 7 (11), 1101–1112.
   PubMed Web of Science ®Google Scholar
• Dikici, S., et al., 2012. İlk Basamak Sağlık Merkezine Başvuran Hastalarda Baş Ağrısının Özellikleri Ve Etkili Olabilecek Etmenlerin Belirlenmesi. Dicle Tıp Dergisi, 39 (1), 35–41.
   Google Scholar
• Fenech, M., 2000. The in vitro micronucleus technique. Mutation Research, 455 (1–2), 81–95.
   PubMed Web of Science ®Google Scholar
• Fenech, M., 2007. Cytokinesis-block micronucleus cytoma assay. Nature Protocols, 2 (5), 1084–1104.
   PubMed Web of Science ®Google Scholar
• Fenech, M., 1993. The cytokinesis-block micronucleus technique and its application to genotoxicity studies in human populations. Environmental Health Perspectives Supplements, 101, 101–107.
   PubMed Web of Science ®Google Scholar
• Flower, R.J., 2003. The development of COX2 inhibitors. Nature Reviews. Drug Discovery, 2 (3), 179–186.
   Google Scholar
• Francis, B., 2004. COX-3: fact or fancy? Joint Bone Spine. Revue du Rhumatisme, 71 (6), 451–453.
   PubMed Web of Science ®Google Scholar
• Hacıbeyoğlu, G., 2013. Tavşan Diz Eklemine Enjekte Edilen Deksketoprofen Trometamolün Histopatolojik Ve Biyokimyasal Etkilerinin Araştırılması, Konya
   Google Scholar
• Hanna, M.H., et al., 2003. Comparative study of analgesic efficacy and morphine-sparing effect of intramuscular dexketoprofen trometamol with ketoprofen or placebo after major orthopaedic surgery. British Journal of Clinical Pharmacology, 55 (2), 126–133.
   PubMed Web of Science ®Google Scholar
• İnan, N., et al., 2009. Total Kalça Protezi Operasyonlarında İki Multimodal Analjezi Yönteminin Etkinliği. Ağrı, 21 (2), 69–74.
   PubMedGoogle Scholar
• Iohom, G., et al., 2002. Effect of perioperative administration of dexketoprofen on opioid requirements and inflammatory response following elective hip arthroplasty. British Journal of Anaesthesia, 88 (4), 520–526.
   PubMed Web of Science ®Google Scholar
• Jackson, I.D., et al., 2004. Double-blind, randomized, placebo-controlled trial comparing rofecoxib with dexketoprofen trometamol in surgical dentistry . British Journal of Anaesthesia, 92 (5), 675–680.
   PubMed Web of Science ®Google Scholar
• Koç, E., 2010. Küçük Hücreli Olmayan Akciğer Kanserlerinde “Excısıon Repaır Cross-Complementıng Group 1” (Ercc1) Geni T19007c Ve C8092a Tek Nükleotid Polimorfizmlerinin Klinikopatolojik Parametrelerle İlişkilerinin Belirlenmesi, Pamukkale Üniversitesi Sağlık Bilimleri Enstitüsü Yüksek Lisans Tezi Tıbbi Biyoloji Anabilim Dalı, Denizli.
   Google Scholar
• Leval, X., et al., 2002. New trends in dual 5-LOX/COX inhibition. Current Medicinal Chemistry, 9 (9), 941–962.
   PubMed Web of Science ®Google Scholar
• Mauleon, D., et al., 1996. Preclinical and clinical development of dexketoprofen. Drugs, 52 (Supplement 5), 24–46.
   PubMedGoogle Scholar
• Meek, I.L., Mart, A.F., and Vonkeman, H.E., 2010. Non-steroidal antiinflammatory drugs: an overview of cardiovascular risks. Pharmaceuticals, 3, 2146–2162.
   Google Scholar
• Moore, R.A., and Barden, J., 2008. Systematic review of dexketoprofen in acute and chronic pain. BMC Clinical Pharmacology, 8, 11.
   PubMedGoogle Scholar
• Mpountoukas, P., et al., 2010. Cytogenetic evaluation and DNA interaction studies of the food colorants amaranth, erythrosine and tartrazine. Food and Chemical Toxicology, 48 (10), 2934–2944.
   PubMed Web of Science ®Google Scholar
• Öner, S.F., 2010. Ortopedik Alt Ekstremite Cerrahisinde, Postoperatif Analjezi İçin İntravenöz Verilen Deksketoprofen Trometamol “Un Optimal Dozunun Araştırılması. Fırat Üniversitesi Tıp Fakültesi Anesteziyoloji Ve Reanimasyon Anabilim Dalı Uzmanlık Tezi, Elazığ
   Google Scholar
• Ramírez, E., et al., 2013. Drug-induced life-threatening potassium disturbances detected by a pharmacovigilance program from laboratory signals. European Journal of Clinical Pharmacology, 69 (1), 97–110.
   PubMed Web of Science ®Google Scholar
• Sağir, Ö., et al., 2013. Evaluation of the effects of dexketoprofen trometamol on knee joınt: an in vivo & in vitro study, Balikesir, Turkey. Indian Journal of Medical Research, 138, 912–918.
   PubMed Web of Science ®Google Scholar
• Sancher, C.J., et al., 2007. Comparison of intravenous dexketoprofen and dipyrone in acute renal colic. European Journal of Clinical Pharmacology, 63, 751–760.
   PubMed Web of Science ®Google Scholar
• Sav, T., et al., 2012. Single-dose-dexketoprofen-induced acute kidney injury due to massive rhabdomyolysis. International Urology and Nephrology, 44 (5), 1581–1583.
   PubMed Web of Science ®Google Scholar
• Tuncer, S., et al., 2003. Adding ketoprofen to intravenous patient-controlled analgesia with tramadol after major gynecological cancer surgery: a double-blinded, randomized, placebo-controlled clinical trial . European Journal of Gynaecological Oncology, 24 (2), 181–184.
   PubMed Web of Science ®Google Scholar
• Turini, E.M., and Dubois, R.N., 2002. Cyclooxygenase-2: a therapeutic target. Annual Review of Medicine, 53, 35–57.
   PubMed Web of Science ®Google Scholar
• Vane, J.R., and Botting, R.M., 2003. The mechanism of action of aspirin. Thrombosis Research , 110 (5–6), 255–258.
   PubMed Web of Science ®Google Scholar
• Yentür, E.A., 2006. Nonsteroid antienflamatuar ilaçlar. I. Ağrı Bülten, 1, 1.
   Google Scholar
• Zabala, S., et al., 2008. Neutropenia, thrombocytopenia and hepatic injury associated with dexketoprofen trometamol therapy in a previously healthy 35-year-old woman. Journal of Clinical Pharmacy and Therapeutics, 33 (1), 79–81.
   PubMed Web of Science ®Google Scholar
• Zegpi, C., et al., 2009. The effect of opioid antagonists on synergism between dexketoprofen and tramadol. Pharmacological Research, 60 (4), 291–295.
   PubMed Web of Science ®Google Scholar